WallStreetZenWallStreetZen

NASDAQ: AIDX
20/20 Biolabs Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
20/20 Biolabs earnings were -$3.7M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. The latest AIDX earnings report on Dec 31, 2025 announced Q4 2025 earnings of -$1.3M, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AIDX reported annual earnings of -$3.7M, with -32.7% growth.

AIDX earnings history

Current Revenue
$2.0M
Current Earnings
-$3.7M
Current Profit Margin
-182.8%

AIDX Return on Equity

Current Company
-503.1%
Current Industry
8.8%
Current Market
28.9%
AIDX's Return on Equity (-503.1%)... subscribe to Premium to read more.
High Return on Equity Performance

AIDX Return on Assets

Current Company
-96.8%
Current Industry
5.4%
AIDX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when AIDX announces earnings.

AIDX Return on Capital Employed

Current Company
-213.99%
Current Industry
9.4%

AIDX vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
AIDX-$3.50M-$3.74MN/A-$0.76
IRIX-$2.83M-$4.44MN/A-$0.26
PLSM-$5.36M-$5.08MN/A-$0.79
ICCM-$14.80M-$15.06MN/A-$0.24
IINN-$12.73M-$13.22MN/A-$0.45
View Top Medical Device Stocks

20/20 Biolabs Earnings Reports & History FAQ

What were 20/20 Biolabs's earnings last quarter?

20/20 Biolabs (NASDAQ: AIDX) reported Q4 2025 earnings per share (EPS) of -$0.26, up 0% year over year. Total AIDX earnings for the quarter were -$1.31 million. In the same quarter last year, 20/20 Biolabs's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy 20/20 Biolabs stock.

Is 20/20 Biolabs profitable or losing money?

As of the last 20/20 Biolabs earnings report, 20/20 Biolabs is currently losing money. 20/20 Biolabs's net profit (also called net income) for the twelve months ending Dec 31, 2025 was -$3.74 million, a 32.65% decrease year over year.

What was AIDX's earnings growth in the past year?

As of 20/20 Biolabs's earnings date in Q2 2026, 20/20 Biolabs's earnings has grown year over year. AIDX earnings in the past year totalled -$3.74 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.